(Q40339820)

19 September 2017

Progression of liver fibrosis among injection drug users with chronic hepatitis C. (English)

1 reference

19 September 2017

1 reference

Nezam Afdhal

10

0 references

Jacquie Astemborski

series ordinal

3

object named as

Jacquie Astemborski

1 reference

19 September 2017

7

Shruti Mehta

1 reference

19 September 2017

8

Gregory D Kirk

1 reference

19 September 2017

9

Kenrad Nelson

1 reference

19 September 2017

2

Michael Torbenson

1 reference

19 September 2017

11

David L Thomas

1 reference

19 September 2017

6

Rudra Rai

1 reference

19 September 2017

5

Charles Spoler

1 reference

19 September 2017

Lucy E Wilson

1

1 reference

PubMed ID

16557548

19 September 2017

Hawazin Faruki

series ordinal

4

1 reference

PubMed ID

16557548

19 September 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

43

1 reference

19 September 2017

4

1 reference

19 September 2017

788-795

1 reference

Association of hepatitis C virus infection with false-positive tests for syphilis

19 September 2017

1 reference

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

1 reference

7 January 2021

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

1 reference

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

7 January 2021

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users

1 reference

7 January 2021

High prevalence of occult hepatitis B in Baltimore injection drug users

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

1 reference

7 January 2021

Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns

1 reference

7 January 2021

A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.

1 reference

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

7 January 2021

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

1 reference

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

7 January 2021

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

7 January 2021

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

7 January 2021

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

1 reference

7 January 2021

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

7 January 2021

Racial differences in the relationship between hepatitis C infection and iron stores

1 reference

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

7 January 2021

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

7 January 2021

Progression of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Rate of natural disease progression in patients with chronic hepatitis C.

1 reference

7 January 2021

Progression of fibrosis in untreated patients with hepatitis C virus infection

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21091

1 reference

19 September 2017

1 reference

PubMed ID

16557548